Bevacizumab in Treating Patients With Angiosarcoma

NCT00288015 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

BIOLOGICAL: Bevacizumab

Sponsor

Northwestern University

Collaborators

[object Object]